EMORY INTEGRATED PROTEOMICS SHARED RESOURCE PROJECT SUMMARY / ABSTRACT The mission of the Emory Integrated Proteomics Shared Resources (Proteomics SR) is to provide protein analytical services using cutting-edge mass spectrometry (MS) in support of Winship Cancer Institute. The main technology platform of Proteomics SR is liquid chromatography coupled with tandem mass spectrometry (LC- MS/MS) for highly sensitive identification and quantification of proteins and their post-translational modifications (PTMs). Proteomics SR is a critical technological resource for Winship investigators and has supported a broad range of cancer projects related to cancer cell biology, genetics, epigenetics, and novel therapeutics. The primary aims of the of Proteomics SR are to provide: (1) access to state-of-the-art mass spectrometry for both discovery and targeted proteomic applications, (2) provide consultation, expert training, and support for proteomics-related research projects, and (3) provide infrastructure and resources that advance collaborative multidisciplinary research and innovation among Winship investigators. Collectively, these aims will lead to an increase in the quality of proteomics data available to Winship investigators through experimental design optimization and proper interpretation. The mass spectrometry technologies provided are vital to Winship researchers and key findings from these proteomic studies are fundamental to Winship's efforts to improve the prevention, detection, and treatment of human cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA138292-09
Application #
9280115
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
9
Fiscal Year
2017
Total Cost
$55,689
Indirect Cost
$21,178
Name
Emory University
Department
Type
Domestic Higher Education
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Danish, Hasan; Ferris, Matthew J; Balagamwala, Ehsan et al. (2018) Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma. Melanoma Res 28:120-125
Barwick, Benjamin G; Scharer, Christopher D; Martinez, Ryan J et al. (2018) B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat Commun 9:1900
Liu, Fakeng; Liu, Yuan; Liu, Xiuju et al. (2018) Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer 123:36-43
Kennedy, E M; Powell, D R; Li, Z et al. (2018) Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer. Sci Rep 8:6709
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain Behav Immun 74:291-295
Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M et al. (2018) Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer 124:775-784
Jhaveri, Jaymin; Chowdhary, Mudit; Zhang, Xinyan et al. (2018) Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. J Neurosurg :1-7
Jhaveri, Jaymin; Rayfield, Lael; Liu, Yuan et al. (2018) Impact of intensity modulated radiation therapy on survival in anal cancer. J Gastrointest Oncol 9:618-630
Bilen, Mehmet Asim; Dutcher, Giselle Marie Almeida; Liu, Yuan et al. (2018) Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer 16:e563-e575
Chowdhary, Mudit; Switchenko, Jeffrey M; Press, Robert H et al. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol 139:689-697

Showing the most recent 10 out of 331 publications